In Vivo Reprogramming in Regenerative Medicine: Stem Cell Biology and Regenerative Medicine
Editat de Açelya Yilmazeren Limba Engleză Hardback – dec 2017
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 544.55 lei 38-44 zile | |
Springer International Publishing – 31 aug 2018 | 544.55 lei 38-44 zile | |
Hardback (1) | 625.20 lei 6-8 săpt. | |
Springer International Publishing – dec 2017 | 625.20 lei 6-8 săpt. |
Din seria Stem Cell Biology and Regenerative Medicine
- 15% Preț: 628.74 lei
- 18% Preț: 625.04 lei
- 18% Preț: 938.66 lei
- 18% Preț: 879.44 lei
- 18% Preț: 1099.79 lei
- 18% Preț: 1095.95 lei
- 18% Preț: 1525.04 lei
- 18% Preț: 1197.53 lei
- 18% Preț: 1254.72 lei
- 18% Preț: 929.39 lei
- 18% Preț: 1254.27 lei
- 5% Preț: 763.40 lei
- 18% Preț: 1252.09 lei
- 18% Preț: 928.16 lei
- 18% Preț: 930.30 lei
- 18% Preț: 932.01 lei
- 18% Preț: 934.33 lei
- 15% Preț: 677.15 lei
- 18% Preț: 1195.98 lei
- 18% Preț: 937.43 lei
- 15% Preț: 630.15 lei
- 18% Preț: 1204.95 lei
- 15% Preț: 679.69 lei
- 18% Preț: 925.84 lei
- 15% Preț: 678.74 lei
- 18% Preț: 1197.20 lei
- 15% Preț: 682.08 lei
- 18% Preț: 940.53 lei
- 18% Preț: 944.38 lei
- 18% Preț: 1352.46 lei
- 15% Preț: 676.48 lei
- 15% Preț: 628.89 lei
- 18% Preț: 1800.12 lei
- 15% Preț: 633.06 lei
- 18% Preț: 1095.95 lei
- 5% Preț: 761.81 lei
- 18% Preț: 1197.20 lei
- 18% Preț: 1216.53 lei
Preț: 625.20 lei
Preț vechi: 735.54 lei
-15% Nou
Puncte Express: 938
Preț estimativ în valută:
119.69€ • 124.41$ • 99.23£
119.69€ • 124.41$ • 99.23£
Carte tipărită la comandă
Livrare economică 05-19 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319657196
ISBN-10: 3319657194
Pagini: 87
Ilustrații: XVII, 103 p. 15 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.35 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Humana
Seria Stem Cell Biology and Regenerative Medicine
Locul publicării:Cham, Switzerland
ISBN-10: 3319657194
Pagini: 87
Ilustrații: XVII, 103 p. 15 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.35 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Humana
Seria Stem Cell Biology and Regenerative Medicine
Locul publicării:Cham, Switzerland
Cuprins
Chapter 1. Introduction to in vivo cell Reprogramming Technology.- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells.- Chapter 3. Direct Reprogramming to Beta Cells.- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration.- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency.- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration.- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology.
Notă biografică
Dr. Açelya Yilmazer is as an assistant professor at the Biomedical Engineering Department and the vice director of the Stem Cell Institute of Ankara University. After receiving a BSc in Biology from the Middle East Technical University, she completed her MSc degree in Cancer Immunotherapy at the University of Nottingham and obtained her PhD in the Nanomedicine Lab based in the School of Pharmacy, University College London. She has been selected as the Best Young Investigator in Turkey by the Turkish Society of Medical Biology and Genetics. Her research laboratory focuses on cell reprogramming technologies and development of novel nanomaterial systems for directing cell fate. She is a member of the International Society of Stem Cell Research and the Biomaterials and Tissue Engineering Society of Turkey.
Textul de pe ultima copertă
There have been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. Therefore, in vivo reprogramming has emerged as a novel treatment technology. In the process of in vivo reprogramming, cells switch to another cell type within the living organism. Leaders in the field discuss how in vivo reprogramming can be used for tissue repair and regeneration in different organs, including pancreas, liver and heart. Furthermore, recent studies on in vivo cell reprogramming towards pluripotency are also reviewed. Current challenges of these preclinical studies are discussed and hypothesis and suggestions are given in order to improve the current strategies to achieve translation into clinic.
Caracteristici
Reviews the most relevant in vivo reprogramming studies, offering a critical assessment of this potentially powerful technology Explores preclinical studies on animal models providing groundwork for researchers and clinicians to direct the future of in vivo reprogramming and its approaches to clinical settings Contributors culled from top institutions worldwide provide international perspective and expertise